ROBERTO PILI joined the Indiana University Melvin and Bren Simon Cancer Center. Pili will direct the genitourinary research program at the cancer center and serve as the medical director of the genitourinary clinical program at the IU Health Simon Cancer Center.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
